Dr. Dilpesh S. Agrawal, MD

Dr. Agrawal practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Agrawal's NPI, 1407134422, was assigned on July 25, 2011. Dr. Agrawal holds Wisconsin license 61712.

Dr. Agrawal's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Agrawal's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. Dr. Agrawal is also affiliated with Froedtert West Bend Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Agrawal to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agrawal practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Agrawal's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Agrawal is licensed in Wisconsin.

CMS data shows 137 Medicare services from Dr. Agrawal across 5 procedure codes in 2024, for 130 Medicare patients. Medicare paid $14,129 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 130 Medicare patients who saw Dr. Agrawal in 2024. The largest group is 65 to 74, with 61 patients. 68% of them have high blood pressure, and 62% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agrawal's median patient age at 53, with 51% women.

In 2024, Dr. Agrawal wrote 344 Medicare Part D claims for 99 patients. 63% of them were for generic drugs. CMS names the drug for 217 of them, across 8 drugs with 11 or more claims each, at $1,395,418 in total drug cost. In 2023, CMS named 136 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Agrawal for performance year 2024, reported as part of a group. Dr. Agrawal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agrawal as offering telehealth. CMS counts 74 procedures of colonoscopy by Dr. Agrawal, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Agrawal, published from 2015 to 2023. The most frequent topics are Deglutition. Dr. Agrawal has published most often in Neurogastroenterol Motil. Dr. Agrawal's most frequent co-authors are Reza Shaker, MD, Francis Ogbonna Edeani, MD and Gokulakrishnan Balasubramanian, MD.

CMS Open Payments shows 14 general payments to Dr. Agrawal from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,366.